021-51111890
购物车（）
sales@molnova.cn
AKOS037652256
CAS No. 2171065-77-1
AKOS037652256 ( —— )
产品货号. M36433 CAS No. 2171065-77-1
AKOS037652256 can be used as a TRPML modulator for the treatment of diseases associated with TRPML activity such as lysosomal accumulation disorders, muscular dystrophy, common age-related neurodegenerative diseases, oxidative stress or reactive oxygen species (ROS)-related diseases and ageing.
纯度: >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| 规格 | 价格/人民币 | 库存 | 数量 |
| 2MG | ￥2519 | 有现货 |
|
| 5MG | ￥3553 | 有现货 |
|
| 10MG | ￥5233 | 有现货 |
|
| 25MG | ￥7718 | 有现货 |
|
| 50MG | ￥10870 | 有现货 |
|
| 100MG | ￥14306 | 有现货 |
|
| 500MG | 获取报价 | 有现货 |
|
| 1G | 获取报价 | 有现货 |
|
生物学信息
-
产品名称AKOS037652256
-
注意事项本公司产品仅用于科研实验，不得用于人体或动物的临床与诊断
-
产品简述AKOS037652256 can be used as a TRPML modulator for the treatment of diseases associated with TRPML activity such as lysosomal accumulation disorders, muscular dystrophy, common age-related neurodegenerative diseases, oxidative stress or reactive oxygen species (ROS)-related diseases and ageing.
-
产品描述AKOS037652256 can be used as a TRPML modulator for the treatment of diseases associated with TRPML activity such as lysosomal accumulation disorders, muscular dystrophy, common age-related neurodegenerative diseases, oxidative stress or reactive oxygen species (ROS)-related diseases and ageing.
-
体外实验——
-
体内实验——
-
同义词——
-
通路Others
-
靶点Other Targets
-
受体Others
-
研究领域——
-
适应症——
化学信息
-
CAS Number2171065-77-1
-
分子量553.07
-
分子式C24H26ClFN4O4S2
-
纯度>98% (HPLC)
-
溶解度——
-
SMILESCN(C)S(=O)(=O)c1ccc(cc1)S(=O)(=O)Nc1ccccc1N1CCN(CC1)c1ccc(Cl)cc1F
-
化学全称——
运输与储存
-
储存条件(-20℃)
-
运输条件With Ice Pack
-
稳定性≥ 2 years
参考文献
产品手册
关联产品
-
7-Troc-paclitaxel
7-Troc-paclitaxel 是紫杉醇的前体，具有抗肿瘤活性。
-
Longikaurin E
Longikaurin E 是一种胰腺癌治疗剂。它是从腺蝽中分离出来的。
-
1-(3,4-dimethoxyphen...
1-(3,4-Dimethoxyphenyl)-2-(4-allly-2,6-dimethoxyphenoxy)propan-1-ol shows anti-staphylococcal activity against a total of five multidrug-resistant (MDR) and methicillin-resistant Staphylococcus aureus strains and the minimum inhibitory concentrations (MICs) are in the range of 128-256 ug/ml.
